M. Josep Martí
Sobre mi
Dra Marti received her MD at the University of Barcelona (UB), the Degree in Neurology in 1985 and the PhD in 1994 directed by Prof. Eduardo Tolosa. She enjoyed a postdoctoral fellowship in the Columbia University under the supervision of Prof. Robert Burke. She was the Head of the Parkinson and Movement Disorders Unit at the Hospital Clínic of Barcelona and associated Professor of the UB until 2020. She is an IDIBAPS researcher and director of the Parkinson disease and Movement Disorders Lab and PI of the Parkinson Group at CIBERNED. She is also de Coordinator of the Center of Reference CSUR for Rare disease with Movement Disorders and the Director of the Hospital Clinic Health Care Provider of the ERN-RND.
Publicacions destacades
-
Prediabetes, type 2 diabetes mellitus and risk of Parkinson's disease: A population-based cohort study
Autors:Referència: Parkinsonism & Related Disorders 2021. -
Progression of Motor and Non-Motor Symptoms in Multiple System Atrophy: A Prospective Study from the Catalan-MSA Registry
Autors:Referència: Journal Of Parkinsons Disease 2021. -
MicroRNADeregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways
Autors:Referència: Movement Disorders 2020. -
Correlates of cerebrospinal fluid levels of oligomeric-and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
Autors:Referència: Journal Of Neurology 2015. -
Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry
Autors:Referència: Parkinsonism & Related Disorders 2015. -
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Autors:Referència: Brain 2009.
Projectes destacats
-
2017 SGR 1502 (AGAUR)
Investigador/a principal: MariaJosé Martí DomènechFinançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento)Durada: 26/02/2018 - 01/01/2020 -
Amplificación de autoagregación de alfa-sinucleína y 4R-tau en tejido cerebral y líquido cerebrospinal mediante RTQuIC como biomarcador diferencial de parkinsonismos degenerativos
Investigador/a principal: Yaroslau Compta HirnyjFinançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Instituto de Salud Carlos IIIDurada: 01/01/2018 - 31/10/2021 -
Identification of pathophysiological pathways and candidate biomarkers in the prediagnostic phase of Parkinson’s disease’
Investigador/a principal: Eduardo Tolosa SarroFinançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Health Institute Carlos III (ISCIII)Durada: 10/09/2016 - 10/09/2018 -
Catalan Network of Multiple System Atrophy: Biomarkers and Pathophysiology’
Investigador/a principal: Maria José Martí DomènechFinançador: Hospital Clinic de Barcelona (Sede o evento); Fundació Marató TV3Durada: 01/01/2014 - 01/01/2017 -
Combined use of neuropsychological, biochemical, and neuroimaging biomarkers for assessment of risk of dementia in Parkinson disease
Investigador/a principal: Maria José Martí DomènechFinançador: Hospital Clinic de Barcelona (Sede o evento); Fundació Marató TV3 605010Durada: 01/01/2007 - 01/01/2010